Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- Blueprint Medicines Submits NDA to the FDA for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
- Updated Efficacy Data from GBT’s Phase 3 Study Show Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor
- Janssen Reports Top-Line Phase 3 Results for Tremfya in Adults with Active Psoriatic Arthritis
- Bristol-Myers Squibb Announces Empliciti-Based Combination Showed Improvements Across All Efficacy Endpoints in Phase 2 Trial in Multiple Myeloma
- Enanta’s EDP-938 Achieved its Primary and Secondary Endpoints in Phase 2a Human Challenge Study in Healthy Adults with Respiratory Syncytial Virus
- FDA Approves Amgen and Allergan’s Kanjinti, a Biosimilar to Herceptin
- GSK Forms Drug Discovery Alliance with University of California CRISPR Researchers
- AbCellera and Gilead Enter Infectious Disease Therapeutic Antibody Discovery Collaboration
- Bone Therapeutics’ Allogeneic Cell Therapy Product Meets Primary Endpoints in Phase 2a Study in Patients Undergoing Lumbar Spinal Fusion
- Phase 3 Study Showed that Genentech’s Rituxan is Superior to Standard of Care in Achieving Sustained Remission in Pemphigus Vulgaris